HyperglycemiaHypoglycemiaCritical IllnessBlood GlucoseInsulinHypoglycemic AgentsGlucoseDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1Critical CareIntensive Care UnitsGlucagonDiabetes Mellitus, Type 2HyperinsulinismDiabetes MellitusHemoglobin A, GlycosylatedGlucose Clamp TechniqueTerminally IllStreptozocinGlucose Tolerance TestIntensive CareEpinephrineIslets of LangerhansInsulin Infusion SystemsBlood Glucose Self-MonitoringC-PeptidePancreatic PolypeptideInsulin, Long-ActingFastingTime FactorsGluconeogenesisSepsisPostprandial PeriodInsulin-Secreting CellsInsulin ResistanceAPACHEDiabetes ComplicationsGlucokinaseRespiration, ArtificialProspective StudiesInfusions, IntravenousMonitoring, PhysiologicDiabetic AngiopathiesGlycosuriaTreatment OutcomeRetrospective StudiesAcute Kidney InjuryInsulin ComaEnteral NutritionHydrocortisoneClinical AlarmsPhlorhizinRisk FactorsLiverPregnancy in DiabeticsRats, Sprague-DawleyDiabetic KetoacidosisSulfonylurea CompoundsGlucagon-Like Peptide 1Acute DiseaseBody WeightFatty Acids, NonesterifiedMultiple Organ FailureReference ValuesGlucose IntolerancePancreas, ArtificialPancreasGlipizideVentromedial Hypothalamic NucleusHemofiltrationHospital MortalityHomeostasisInsulinomaNutritional SupportDiabetic NephropathiesLactic AcidDisease Models, AnimalRats, WistarHemodiafiltrationNesidioblastosisIntensive Care Units, PediatricCongenital HyperinsulinismBiological MarkersHyperglycemic Hyperosmolar Nonketotic ComaNorepinephrineDiazoxideMetforminSeverity of Illness IndexDiabetic Neuropathies3-Hydroxybutyric AcidMice, Inbred C57BLRenal Replacement TherapyOxidative StressAcarbosePancreatectomyDipeptidyl-Peptidase IV InhibitorsGlucagon-Secreting CellsGlycogenLactatesDose-Response Relationship, Drug